Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$132.81 - $182.18 $5,710 - $7,833
-43 Closed
0 $0
Q3 2020

Oct 29, 2020

BUY
$114.09 - $145.51 $1,711 - $2,182
15 Added 53.57%
43 $6,000
Q2 2020

Aug 10, 2020

SELL
$89.45 - $129.85 $268,171 - $389,290
-2,998 Reduced 99.07%
28 $3,000
Q1 2020

Apr 22, 2020

SELL
$70.23 - $144.31 $26,757 - $54,982
-381 Reduced 11.18%
3,026 $303,000
Q4 2019

Jan 29, 2020

BUY
$76.41 - $117.54 $260,328 - $400,458
3,407 New
3,407 $400,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.